Skip to content

A Clinical Trial on Neiguan Acupoint Electrical Stimulation for Preventing Postoperative Nausea and Vomiting under General Anesthesia

A Clinical Trial on Neiguan Acupoint Electrical Stimulation for Preventing Postoperative Nausea and Vomiting under General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078731
Enrollment
Unknown
Registered
2023-12-18
Start date
2023-12-18
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting under general anesthesia

Interventions

control group:wear transcutaneous electrical acupoint stimulation eqiupment,not turned on

Sponsors

the Second People's Hospital of Pingxiang City
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients undergo hysteroscopic elective surgery, aged 20-50 years old, ASA I-II grade, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who experience nausea and vomiting 24 hours before surgery and have taken antiemetic medication; (2) Pregnant and lactating women; (3) Patients with abnormal heart, lung, liver, and kidney functions; (4) Patients who refuse acupoint electrical stimulation treatment.

Design outcomes

Primary

MeasureTime frame
incidence of PONV;

Secondary

MeasureTime frame
score of PONV;satisfaction score of anesthesia;

Countries

China

Contacts

Public ContactZeng Lin

The Second People's Hospital of Pingxiang City, Jiangxi Province

zenglin0715@126.com+86 138 7997 5508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026